Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trial

20260 citationsJournal Articlegold Open Access

Authors

Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394.

Partnerships for the goals

Published in: EClinicalMedicine

Volume 92, pp. 103760-103760

Field-Weighted Citation Impact: 0.00